Would You Consider Undergoing Online Ketamine-Assisted Psychotherapy?

October 12, 2020 13:39:23

The COVID-19 pandemic has brought with it immense challenges for all sections of society, including the nascent field of psychedelic-assisted psychotherapy. In the new norm of social distancing and the constant threat that stay-at-home orders will be reissued in places where they have been eased, it is necessary to consider new approaches of doing things. Virtual ketamine-assisted psychotherapy (“KAP”) sessions are one of the new developments to consider if you are a patient who now finds yourself unable to visit the ketamine clinic you used to frequent for sessions before the pandemic struck. Here are some of the reasons that make online ketamine-assisted psychotherapy desirable.

Online KAP is More Affordable

The standard or in-clinic KAP sessions demand anywhere from 10-20 hours per session. This time goes to the intake with a therapist, time spent with a physician, the hours spent preparing, the time that goes to experiential sessions and the time allocated to psychedelic integration therapy after the sessions. Patients therefore have to fork out a large sum of money for the treatment, and since insurance…

Read More >>

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]

PsychedelicNewsWire is part of the InvestorBrandNetwork.